Cellectis (CLLS) Net Margin (2015 - 2026)
Cellectis' Net Margin came in at -417.27% for Q2 2026, down 166.97 percentage points from -250.30% a year earlier and down 109.76 percentage points from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Net Margin (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cellectis reported Net Margin of -110.90%, up 26.10 percentage points year-over-year; for FY2025, it was -92.66%, down 4.09 percentage points from FY2024.
- Net Margin carries a five-year change of +27.44 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -88.57% in FY2024 (+13296.73 pp), -13385.30% in FY2023 (-12831.65 pp), -553.64% in FY2022 (-177.34 pp) and -376.30% in FY2021 (-256.21 pp).
- The Q2 2026 figure represents the lowest quarterly Net Margin since Q4 2023.
- Year-over-year, Net Margin has declined for three consecutive quarters, with an average year-over-year change of +3163.26 percentage points over the last eight quarters.
- The fastest year-over-year change in Net Margin over five years came in Q1 2024 (a gain of 21760.60 percentage points), and the weakest in Q1 2023 (a drop of 19719.39 percentage points).
- Business Quant data shows CLLS's Net Margin at -307.51% (Q1 2026), -206.97% (Q4 2025) and 1.67% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.99 Bn | 1,104.58 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 616.90 Bn | 535.42 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 501.56 Bn | 474.68 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.45 Bn | 235.13 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 236.48 Bn | 191.88 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 190.56 Bn | 164.76 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | -1.65% |
| 10 | Cellectis | 95.27 Mn | -658.13 Mn | - | -417.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -417.27% |
| Mar 31, 2026 | -307.51% |
| Dec 31, 2025 | -206.97% |
| Sep 30, 2025 | 1.67% |
| Jun 30, 2025 | -250.30% |
| Mar 31, 2025 | -170.14% |
| Dec 31, 2024 | 46.57% |
| Sep 30, 2024 | -142.32% |
| Jun 30, 2024 | -313.48% |
| Mar 31, 2024 | 124.62% |
| Dec 31, 2023 | -14,768.55% |
| Sep 30, 2023 | -11,278.71% |
| Jun 30, 2023 | -6,576.97% |
| Mar 31, 2023 | -21,635.97% |
| Dec 31, 2022 | -167.34% |
| Sep 30, 2022 | -16,266.86% |
| Jun 30, 2022 | -1,454.63% |
| Mar 31, 2022 | -1,916.58% |
| Dec 31, 2021 | -243.59% |
| Sep 30, 2021 | -450.11% |
API Access
Cellectis Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();